(1)
Hadeel Delman Najim; Mohammed Mahmood Mohammed; Abbas Mahdi Rahmah. Influence of Adding Empagliflozin to Conventional Anti-Diabetic Therapy on Quality of Life Scale for Type 2 Diabetic Patients. Iraqi Journal of Pharmaceutical Sciences 2024, 33 (3), 142-149. https://doi.org/10.31351/vol33iss3pp142-149.